Why Equi Sciences

Industry Outlook

The industry outlook for clinical trials in the United States is very promising, with a projected Compound Annual Growth Rate (CAGR) of 5% from 2022 to 2030. However, despite the substantial volume of scheduled and ongoing trials nationwide, minority representation in these studies remains disproportionately low, accounting for only 4 to 5 percent of participants. This disparity presents a significant opportunity for EQUI Sciences, which is dedicated to educating and recruiting minority groups for participation in clinical research, thereby addressing the critical need for greater inclusivity and diversity in medical studies.
Industry outlook

Equi Sciences is revolutionizing the world of clinical research and drug development. We are dedicated to pushing boundaries and driving innovation by embracing diversity. Recognizing the importance of inclusivity in clinical trials, we are committed to ensuring the safety, efficacy, and relevancy of medical treatments.

 

Contact Us

Spartanburg, South Carolina, United States

 

Subscribe to Our Newsletter

Subscribe to our newsletter for the latest updates and exclusive offers.

Copyright © 2024 Divi. All Rights Reserved.